Stay updated on Semaglutide in Heart Failure & Obesity: Clinical Trial

Sign up to get notified when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide in Heart Failure & Obesity: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The latest version adds updated Contacts/Locations and Study Status. It also removes the 2025-02-26 entry from the history.
    Difference
    0.2%
    Check dated 2025-12-08T20:18:57.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer revision updated to Revision: v3.3.2, replacing Revision: v3.3.1. This reflects a minor site update that does not affect study content or user-interactive features.
    Difference
    0.0%
    Check dated 2025-12-01T16:47:57.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page footer. No study record details or history entries were altered in this update; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:39:09.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. This change eliminates an administrative status banner without altering the core study information.
    Difference
    0.3%
    Check dated 2025-11-17T06:33:45.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Two screenshots show minor UI/layout adjustments in the Study Record History page, with no visible changes to core trial data such as status, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T01:13:30.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    8%
    Check dated 2025-10-05T10:21:07.000Z thumbnail image

Stay in the know with updates to Semaglutide in Heart Failure & Obesity: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.